In summary, here, we provide evidence of a neuroprotective effect of the pharmacological inhibition of C5a-C5aR1 signaling in the pathology progression in the Tg2576 mouse model of Alzheimer’s disease. This evidence concerns the gene C5 and Alzheimer disease.